Logo Image
News
All NewsFDA UpdatesPress Releases
Watch
Expert ConversationsNews & AnalysisShows & PodcastsSponsored Webcast
Conferences
Conference CoverageConference Listing
Publications
All PublicationsPharmacy TimesPharmacy Practice in Focus: OncologyPharmacy Practice in Focus: Health SystemsPharmacy CareersAuthor SubmissionSubmit to Pharmacy Practice in Focus: OncologySubmit to Pharmacy Practice in Focus: Health SystemsBecome a Peer ReviewerSupplements & Featured Publications
More
Events
Upcoming EventsUpcoming Webinars
CE
Resources
Clinical ForumAmerican Heart MonthThe Bispecifics NetworkEducated PatientInformation for the PharmacistInteractive ToolsMicrositesPartnersPulsePointSponsoredWhiteboards

Subscribe

  • News
  • Watch
  • Conferences
  • Publications
  • Events
  • CE
  • Resources
  • Subscribe
  • 503B Compounding Pharmacy
  • Allergy
    • Asthma
  • Biosimilars
  • Cardiovascular Health
    • Heart Failure
    • Cholesterol
  • Chronic Kidney Disease
  • Classical Hematology
    • Immunoglobulins
    • Neutropenia
  • Dermatology
    • Psoriasis
    • Atopic Dermatitis
  • Endocrinology
    • Continuous Glucose Monitoring
    • Diabetes
    • Osteoporosis
  • Eye Care
    • Macular Degeneration
    • Dry Eye Disease
  • Future of Pharmacy
  • Gastrointestinal Health
    • Digestive Health
  • Hematology
    • Multiple Myeloma
    • Lymphoma
    • Myelofibrosis
    • Chronic Lymphocytic Leukemia
  • Hepatitis/MASH
  • Infectious Disease
    • Respiratory Syncytial Virus
    • Pneumococcal
    • C. difficile
    • COVID-19
    • Flu
    • HIV
    • PrEP
    • COVID Treatment
  • Neurology
    • Multiple Sclerosis
    • Alzheimer Disease
    • Epilepsy
    • Migraine
    • Sleep
    • Shingles
    • Alzheimer Disease
    • Movement Disorders
    • Parkinson Disease
  • Oncology
    • Cholangiocarcinoma
    • Endometrial Cancer
    • Immuno-oncology
    • Genitourinary Cancer
    • Lung Cancer
    • Prostate Cancer
    • Skin Cancer
    • Ovarian Cancer
    • Breast Cancer
    • Cervical Cancer
    • Gastrointestinal Cancer
    • Colorectal Cancer
    • HER2 Breast Cancer
  • Pain Management
  • Pediatrics
  • Psychiatry
    • Psychedelics
    • Schizophrenia
    • ADHD
    • Brain Health
    • Mental Health
    • Bipolar Disorder
    • Anxiety
    • Depression
  • Pulmonology
    • COPD
    • Cough and Cold
  • Rheumatology
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
  • Vaccines
    • Travel Vaccines
  • Veterinary Pharmacy
  • Vitamins and Supplements
  • Weight Management
  • Women's Health
    • Reproductive Health
Spotlight -
Community/Retail|
Hospital|
Oncology|
Pharmacy Technician|
Student
Advertisement

TOLL-FREE NUMBER ON DRUG PRODUCTS DELAYED

By
February 1st 2008

IT'S COMING: PHARMACISTS PRESCRIBING DRUGS

By
February 1st 2008

FDA ISSUES DRAFT GUIDANCE ON OFF-LABEL DRUG USE

By
February 1st 2008

Drug Diversion and Abuse: Methadone: Friend or Foe?

ByCmdr John Burke
February 1st 2008

Although methadone is often legitimately prescribed as a painkiller, it continues to be abused—pharmacists should remain aware.

Pharmacy Law: Do Patients Have a Right to Investigational Drugs?

ByJoseph L. Fink III, BSPharm, JD
February 1st 2008

Should the terminally ill have special access to experimental drugs?

Kawar's Leadership Earns Her RESPy Award

ByBarbara Sax
February 1st 2008

Kathleen Kawar, the latest RESPy Award winner, has shown significant leadership skills to advance the pharmacy profession.

Off-label Uses for Treating Pain

ByMelinda J. Throm, PharmD, BCPS
February 1st 2008

Safe, effective off-label prescribing begins with an understanding of clinical and legal implications of such actions.

Colonoscopy: Extremely Beneficial—Extremely Avoided

ByGuido R. Zanni, PhD
February 1st 2008

Effective patient counseling decreases the high number of patients who avoid this preventive screening procedure.

Did You Know?? Fear of Meds Reduces Patient Adherence

ByGuido R. Zanni, PhD
February 1st 2008

Patients may decide not to fill a prescription or take a medication because of potential adverse effects.

Chronic Care Focus: Important Considerations for Managing Essential Hypertension

ByAntony Q. Pham, PharmD
February 1st 2008

Lifestyle modifications are usually the first defense against hypertension; however, various pharmacologic options exist.

2-minute Consultation: Dementia: Many Facets, No Cure

ByJeannette Yeznach Wick, RPh, MBA, FASCP
February 1st 2008

Dementia is a growing concern for the aging population.

Side Effect Solutions: How to Avoid Medication-induced Weight Gain

ByDawn S. Knudsen, PharmD
February 1st 2008

Pharmacists often see patients attributing weight gain to their medications or wanting to know if a new drug might lead to it.

Editor's Note: Creating an Intermediate Class of Drugs

ByJames C. McAllister III, MS, FASHP
February 1st 2008

Is a third class of drugs on the horizon for pharmacy?

GREENSTONE WINS DIANA AWARD AS TOP GENERIC PHARMACEUTICAL FIRM

By
February 1st 2008

PART D "DOUGHNUT HOLE" EFFECT DRIVES UP GENERIC Rx DEMAND

By
February 1st 2008

TOO MANY RETIREES IGNORE GENERIC Rx SAVINGS, STUDY FINDS

By
February 1st 2008

Product News

By
February 1st 2008

CANADIAN PHARMACISTS DEFEND GENERIC REBATES

By
February 1st 2008

Helping Hepatitis Patients Manage Their Disease

ByCheryl A. Grandinetti, PharmD
February 1st 2008

Pharmacists can improve care of patients with hepatitis B or C through recommendations, monitoring, and education.

A Pharmacist's Guide to OTC Therapy: February 2008

ByYvette C. Terrie, BSPharm, RPh
February 1st 2008

Community Pharmacist Shortage: Fact or Fiction?

BySam Mahrous, PhD, MBA, CIS,Dorothy Maziarz, PharmD
February 1st 2008

What is being done to address current and projected shortages of community pharmacists?

editor'sNOTE: Behind-the-counter in Our Near Future?

ByFred M. Eckel, RPh, MSPharmacy Times Editor-in-Chief
February 1st 2008

TRICARE PROVISIONS CONTINUE TO MOVE FORWARD

By
February 1st 2008

Product News

By
February 1st 2008
  • Prev
  • 1
  • 2
  • Prev
Advertisement
Advertisement

Trending on Pharmacy Times

1

Phase 3 Trial Marks First Success for Personalized mRNA Cancer Therapy in Resected Melanoma

2

FDA Approves Garetosmab-grts, First Treatment for FOP Bone Growth

3

Fentanyl-Responsive Microneedle Patch Automatically Releases Naloxone in Preclinical Study

4

Delegating to Technicians: The Key to Pharmacists Practicing at Top of License

5

The Main Street Pharmacy Access Act: A Small Bill Asking a Big Question

  • About Us
  • Clinical Forums
  • Advertise
  • Contact Us
  • Editorial Staff
  • Privacy Policy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contemporary Clinic
  • OTC Guide
  • Pharmacy Times
  • Pharmacist Mom's Group
  • Pharmacist Mom's Group
Pharmacy Times
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us